Morphine Sulfate Solution
NDC Package 0054-0237-41
Package Information
Morphine Sulfate solution is a medication used to treat severe pain. This formulation utilizes a solution delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0054-0237 and is authorized under FDA application NDA022195.
Identification & Billing
- RxCUI: 892589 - morphine sulfate 10 MG in 5 mL Oral Solution
- RxCUI: 892589 - morphine sulfate 2 MG/ML Oral Solution
- RxCUI: 892589 - morphine sulfate 10 MG per 5 ML Oral Solution
- RxCUI: 892589 - MS 2 MG/ML Oral Solution
- RxCUI: 892625 - morphine sulfate 20 MG in 1 mL Concentrate for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0054 - Hikma Pharmaceuticals Usa Inc.
- 0054-0237 - Morphine Sulfate
- 0054-0237-41 - 15 mL in 1 BOTTLE
- 0054-0237 - Morphine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0054-0237). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0054-0237-41 identifies a specific commercial package of 15 ml in 1 bottle of Morphine Sulfate, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This solution is formulated for oral use and contains morphine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on March 17, 2008. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00054023741. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.